Diagnostics & Diseases Market Research Reports & Industry Analysis

About This Report This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

This new 68-page report from Venture Planning Group reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

This new report from Venture Planning Group contains 508 pages, 67 tables and presents a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

This new report from Venture Planning Group contains 521 pages, 63 tables and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

This new report from Venture Planning Group contains 520 pages, 64 tables and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

This new report from Venture Planning Group contains 514 pages, 63 tables and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...

This new report from Venture Planning Group contains 543 pages, 63 tables and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...

This new report from Venture Planning Group contains 997 pages, 87 tables and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 897 pages, 77 tables and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 897 pages, 74 tables and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 887 pages, 72 tables and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

This new report from Venture Planning Group contains 891 pages, 75 tables and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

This new report from Venture Planning Group contains 880 pages, 73 tables and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

This new report from Venture Planning Group contains 886 pages, 67 tables and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new 225-page report from Venture Planning Group presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of ...

This new report from Venture Planning Group contains 533 pages, 43 tables and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 530 pages, 40 tables and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 525 pages, 38 tables and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 537 pages, 42 tables and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 521 pages, 41 tables and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

This new report from Venture Planning Group contains 527 pages, 37 tables and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

This new report from Venture Planning Group contains 567 pages, 50 tables and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...

This new report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product ...

This new report from Venture Planning Group provides strategic assessments of major coagulation product suppliers and emerging market entrants. The report presents analyses of major manufacturers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, ...

This new report from Venture Planning Group provides strategic assessments of major suppliers of hematology and flow cytometry instuments and reagants, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product ...

This new report from Venture Planning Group provides strategic assessments of major suppliers of hemostasis diagnostic products, as well as emerging market entrants. The report presents analyses of major current and emerging suppliers of hemostasis instruments ans reagents, including: Sales estimates ...

... new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants. The report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products ...

This new 90-page report from Venture Planning Group provides insightful profiles of leading microbiology market players and recent market entrants. The report presents strategic assessments, including sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative ...

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, ...

... -page report from Venture Planning Group contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, ... of leading suppliers. About This Report This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, ...